AVII found some very fascinating mismatched dates between the FDA documentation for Zytiga approval and the J&J PRs etc.. The timeline seems to have gone like:
a) Jan 2010 (see dates in FDA Statistical Review): Pre-planned interim occurs for OS - Zytiga is VERY stat sig (<0.0001 when alpha was 0.0141).
b) Sept 2010: Final OS analysis for OS (kinda immaterial - but very stat sig)
c) Oct 2010: First J&J PR that they hit the interim (and thus x-over is allowed - but note PR is silent on the fact that they hit that interim 9 months ago).
The updated OS analysis was conducted per the Agency’s request to confirm the OS estimates. The cut-off date for the updated OS analysis was before the first subject crossing over
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.